Understanding an Increasingly Complex Treatment Landscape in Urothelial Carcinoma: Guidance for Frontline Oncology Practitioners

Download All
A comprehensive educational program to equip oncology nurses, nurse practitioners, physician assistants, and pharmacists with up-to-date information to incorporate new and emerging therapies into clinical practice.
Kinjal Patel, PharmD, BCOP
Susan Roethke, CRNP, MSN, AOCN, ANP-BC

Downloadable Slides with Notes

Review slides with commentary in slidenotes from pharmacist and nursing experts on patient counseling, monitoring, and managing adverse events associated with avelumab, enfortumab vedotin, and erdafitinib in urothelial carcinoma.

Kinjal Patel, PharmD, BCOP Susan Roethke, CRNP, MSN, AOCN, ANP-BC Released: January 11, 2021
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Astellas and Seattle Genetics, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings